Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.39B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$352M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
+$330M |
| 4 |
JPMorgan Chase
JPM
|
+$266M |
| 5 |
Amazon
AMZN
|
+$229M |
Top Sells
| 1 |
iShares Russell 2000 ETF
IWM
|
+$722M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$463M |
| 3 |
Invesco WilderHill Clean Energy ETF
PBW
|
+$437M |
| 4 |
Tesla
TSLA
|
+$408M |
| 5 |
Invesco Dorsey Wright Momentum ETF
PDP
|
+$353M |
Sector Composition
| 1 | Technology | 18.23% |
| 2 | Financials | 12.23% |
| 3 | Consumer Discretionary | 9.87% |
| 4 | Healthcare | 9.03% |
| 5 | Communication Services | 7.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1376
Curis
CRIS
$22.7M
| $4.53M | ﹤0.01% |
+20,026
| New | +$4.53M |
|
1377
FibroGen
FGEN
$48.6M
| $4.53M | ﹤0.01% |
5,222
+3,338
| +177% | +$2.9M |
|
|
ICPT
1378
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $4.52M | ﹤0.01% |
195,933
+172,110
| +722% | +$3.97M |
|
1379
Carlyle Group
CG
$24.1B
| $4.51M | ﹤0.01% |
122,631
+19,696
| +19% | +$724K |
|
|
ARNA
1380
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $4.5M | ﹤0.01% |
64,847
-6,291
| -9% | -$436K |
|
1381
iShares Russell Mid-Cap Value ETF
IWS
$14.2B
| $4.49M | ﹤0.01% |
41,034
+9,825
| +31% | +$1.07M |
|
1382
LGI Homes
LGIH
$1.39B
| $4.49M | ﹤0.01% |
30,041
+3,742
| +14% | +$559K |
|
|
WWE
1383
DELISTED
World Wrestling Entertainment
WWE
| $4.48M | ﹤0.01% |
82,629
-27,986
| -25% | -$1.52M |
|
|
DCPH
1384
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $4.48M | ﹤0.01% |
99,868
+88,091
| +748% | +$3.95M |
|
|
EPAY
1385
DELISTED
Bottomline Technologies Inc
EPAY
| $4.48M | ﹤0.01% |
98,911
-9,057
| -8% | -$410K |
|
1386
COPT Defense Properties
CDP
$3.46B
| $4.47M | ﹤0.01% |
169,662
-2,975
| -2% | -$78.3K |
|
1387
Bank of Hawaii
BOH
$2.7B
| $4.46M | ﹤0.01% |
49,825
+34,241
| +220% | +$3.06M |
|
|
ALLK
1388
DELISTED
Allakos
ALLK
| $4.45M | ﹤0.01% |
38,806
+31,790
| +453% | +$3.65M |
|
1389
MacroGenics
MGNX
$100M
| $4.43M | ﹤0.01% |
139,171
+123,240
| +774% | +$3.92M |
|
|
PPD
1390
DELISTED
PPD, Inc. Common Stock
PPD
| $4.43M | ﹤0.01% |
116,959
+36,038
| +45% | +$1.36M |
|
1391
Kulicke & Soffa
KLIC
$2.01B
| $4.42M | ﹤0.01% |
90,065
+43,942
| +95% | +$2.16M |
|
1392
Westlake Corp
WLK
$11.3B
| $4.42M | ﹤0.01% |
49,721
+44,484
| +849% | +$3.95M |
|
1393
Ligand Pharmaceuticals
LGND
$3.23B
| $4.41M | ﹤0.01% |
46,320
+37,536
| +427% | +$3.57M |
|
1394
AMC Networks
AMCX
$357M
| $4.4M | ﹤0.01% |
82,785
+19,547
| +31% | +$1.04M |
|
1395
TG Therapeutics
TGTX
$5.1B
| $4.4M | ﹤0.01% |
91,307
+66,861
| +274% | +$3.22M |
|
1396
PVH
PVH
$3.9B
| $4.4M | ﹤0.01% |
41,581
-43,084
| -51% | -$4.55M |
|
|
CLR
1397
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $4.38M | ﹤0.01% |
169,490
+47,088
| +38% | +$1.22M |
|
1398
First Hawaiian
FHB
$3.19B
| $4.38M | ﹤0.01% |
160,075
+90,417
| +130% | +$2.47M |
|
1399
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$2.99B
| $4.38M | ﹤0.01% |
47,261
-2,124
| -4% | -$197K |
|
1400
Allogene Therapeutics
ALLO
$251M
| $4.38M | ﹤0.01% |
123,961
+101,390
| +449% | +$3.58M |
|